Share price will recover, AMS is pure quality, I cannot think of a better quality stock. Cheers! |
`cge` the share price as dropped around 40p in a short period time on a very small volume. The interims as you say were positive with just one blip the OEM division underperformed, the board say OEM will be put back on track by the end of the year. I am confused why the MMs are forcing the price down ??? |
Dealit - on the back of the price fall i re read the interim report which is actually pretty detailed. Save for the OEM business decline it is fairly positive - lots of new product development and launches, higher margins and loads of cash.
I wonder whether the price weakness is due to a combination of :
* general poor market sentiment with move away from growth stocks to value stocks
* concerns about Brexit impact |
An announcement with regard to OEM would be good and maybe halt the share price dropping South.
"Our financial progress in OEM has been impacted by both a general slow-down in the woundcare market and by one of our US partners deciding to exit the market. Whilst this temporary setback is disappointing, we have multiple opportunities underway to drive future growth through market expansion and from the launch of new products later this year. These new products demonstrate the inherent value of our R&D and Regulatory capabilities which are a key pillar of our strategy to drive organic growth, supporting our OEM customers and end users." |
A lot of very small buys today. I have said this before about AMS 71m in the bank, if things go as last result announcement said that figure will increase, I would like the Board to start buying shares back all IMHO. |
All go up and down together. Commodities, pharmaceuticals, retail...
70% of trades must be bots. |
Today should see an improvement. |
Once the markets stabilize, the shares will be in serious demand. |
Imho just a lot of automatic sell trades based on momentum. Doesn't matter what sector, everything's down. |
Let us hope that we have buyers coming in at these prices lowest share price for a year. The only concern in the results was the drop off in sales in OEM products, which will soon be back on track according to the Chairmans statement. IMHO they will look attractive to a predator at this lower s/p. |
Trading volumes high this week with a high proportion shares going through at mid price. Strange that there have been no RNS notifications of a change of interest in nominee holdings...?? |
Versarien- |
But EPS-based bonuses to the Board.....;-)
Looks like their Partner programme is vulnerable, judging hy Hollister withdrawing from the woundcare sector.
Presume they'd prefer more 'go it alone'? |
I would really like to see a statistical analysis, by company to demonstrate the success, or failure, of share buybacks.
They deliver nothing to the business. |
We need a large investor to believe what I believe and others that AMS are a good solid Company, increasing profit a good product range and growing every year. Maybe too many shares around, Company share buy back would be helpful to drive the share price North. |
I made my first purchase of AMS shares in 2002 around the time I started managing my small cap portfolio and have added progressively. I posted on this B.B. in those early years but I don’t think I’ve posted here on AMS in the last ten years. What a great success AMS has been and I can’t see why that should not continue. A great example of buy, monitor and add. See you in 10 years!! |
Seems to tail off dramatically towards the close. |
Strange sort of day for AMS share price up 6% at one stage and finishes the day up just 1% on very small volume, are MM`s playing games. |
clearly some selling pressure even on the decent results
Market is that way, at the moment, but I'm no seller - we're 20% off the highs, and the success story that is AMS has not changed with these results
HOw the market values that success is , as always, up to the market |
Overall good results - lower turnover growth but excellent margin improvement (3%!)and cash generation. Dividend increased 20% albeit remains modest.
Full yr forecast for eps of 10.2 - achieved 5p in first half. |
AMS never under-performs. H1 Results are good. Cash pile growing at great lick. Quality company, with loads of cash in the bank. |
Good set of results, bank balance increased, eps up 17% dividend up 20%. OEM division under performed though but should be back on track by final results. |
Usually pays to follow Blackrock's lead. |
Bit of a correction gone on today down nearly 6% lets us hope no surprises in the results tomorrow. |
As dealit says: 'meant to be in line with co. expectations' |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
